Benjamin Segal, MD, identifies disease-modifying therapies that can reduce the activity and progression of multiple sclerosis. Dr. Segal explains how DMTs are useful both for patients with relapsing-remitting MS and progressive forms of the disease.

Related Presenters

Benjamin Segal, MD

Neurology
Professor and Chair of the Department of Neurology

View full profile